Truist Financial Corp Atri Cure, Inc. Transaction History
Truist Financial Corp
- $66.7 Billion
- Q2 2025
A detailed history of Truist Financial Corp transactions in Atri Cure, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 21,206 shares of ATRC stock, worth $622,820. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,206
Previous 19,008
11.56%
Holding current value
$622,820
Previous $613,000
13.21%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding ATRC
# of Institutions
238Shares Held
51.9MCall Options Held
32.6KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.71MShares$138 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$136 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.68MShares$108 Million0.05% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3MShares$88.1 Million1.84% of portfolio
-
Macquarie Group LTD Australia, C32.44MShares$71.6 Million0.1% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.36B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...